Palmoplantar Psoriasis
Immunology
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 4(1)
| Drug | Company |
|---|---|
| Deucravacitinib | BRISTOL MYERS SQUIBB CO (BMY) |
Frequently asked questions
How many drugs are in development for Palmoplantar Psoriasis?
BioSniper tracks 1 drug in development for Palmoplantar Psoriasis across 1 company.
How many clinical trials target Palmoplantar Psoriasis?
There are 2 clinical trials targeting Palmoplantar Psoriasis tracked by BioSniper.
Deep-dive into Palmoplantar Psoriasis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis